We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+0.09%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.86B
AUM Growth
+$83M
Cap. Flow
+$153M
Cap. Flow %
2.62%
Top 10 Hldgs %
16.53%
Holding
808
New
59
Increased
345
Reduced
246
Closed
48

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$28.5M
2
LUV icon
Southwest Airlines
LUV
+$19.5M
3
MCHP icon
Microchip Technology
MCHP
+$17.7M
4
MSFT icon
Microsoft
MSFT
+$16.8M
5
LOW icon
Lowe's Companies
LOW
+$16.2M

Sector Composition

Rank Sector Weight
1 Healthcare 23.16%
2 Technology 15.94%
3 Financials 14.63%
4 Consumer Discretionary 10.42%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
251
BeOne Medicines Ltd
ONC
$33.8B
$5.88M 0.1%
+35,000
New +$4.74M
SGEN
252
DELISTED
Seagen Inc. Common Stock
SGEN
$5.86M 0.1%
112,000
VECO icon
253
Veeco
VECO
$2.96B
$5.86M 0.1%
344,459
+37,060
+12% +$645K
VMC icon
254
Vulcan Materials
VMC
$36.9B
$5.84M 0.1%
51,124
-16,498
-24% -$2.08M
SHW icon
255
Sherwin-Williams
SHW
$80.7B
$5.83M 0.1%
44,619
+23,895
+115% +$3.26M
WBA
256
DELISTED
Walgreens Boots Alliance
WBA
$5.79M 0.1%
88,514
+8,484
+11% +$606K
SJR
257
DELISTED
Shaw Communications Inc.
SJR
$5.77M 0.1%
299,907
-202,558
-40% -$4.16M
FNSR
258
DELISTED
Finisar Corp
FNSR
$5.67M 0.1%
358,792
+146,495
+69% +$2.76M
ATVI
259
DELISTED
Activision Blizzard
ATVI
$5.59M 0.1%
82,794
+40,435
+95% +$2.85M
ORLY icon
260
O'Reilly Automotive
ORLY
$75.1B
$5.52M 0.09%
334,515
-4,935
-1% -$83.5K
DHR icon
261
Danaher
DHR
$138B
$5.5M 0.09%
63,329
+3,168
+5% +$277K
HII icon
262
Huntington Ingalls Industries
HII
$11.4B
$5.49M 0.09%
21,295
+17,400
+447% +$4.32M
MXIM
263
DELISTED
Maxim Integrated Products
MXIM
$5.48M 0.09%
91,065
+1,402
+2% +$83.1K
ADP icon
264
Automatic Data Processing
ADP
$102B
$5.48M 0.09%
48,312
-1,793
-4% -$209K
AAL icon
265
American Airlines Group
AAL
$9.9B
$5.45M 0.09%
104,832
+16,311
+18% +$874K
SCHW
266
Charles Schwab
SCHW
$181B
$5.44M 0.09%
104,156
+23,106
+29% +$1.24M
SPGI icon
267
S&P Global
SPGI
$130B
$5.4M 0.09%
28,272
-272
-1% -$50.2K
NBIX icon
268
Neurocrine Biosciences
NBIX
$17.7B
$5.39M 0.09%
65,000
-35,000
-35% -$2.96M
GS icon
269
Goldman Sachs
GS
$309B
$5.35M 0.09%
21,231
-1,722
-8% -$448K
RIGL icon
270
Rigel Pharmaceuticals
RIGL
$692M
$5.33M 0.09%
150,500
+28,500
+23% +$1.14M
MRSH
271
Marsh
MRSH
$87.5B
$5.3M 0.09%
64,161
+12,078
+23% +$1M
RVNC
272
DELISTED
Revance Therapeutics, Inc.
RVNC
$5.27M 0.09%
171,000
+20,000
+13% +$644K
PNW icon
273
Pinnacle West Capital
PNW
$12.8B
$5.23M 0.09%
65,488
-807
-1% -$63.3K
SWK icon
274
Stanley Black & Decker
SWK
$14.6B
$5.2M 0.09%
33,955
+7,243
+27% +$1.18M
CMG icon
275
Chipotle Mexican Grill
CMG
$42.6B
$5.18M 0.09%
802,150
+719,200
+867% +$4.53M

Similar funds

Candriam SCA's Q1 2018 Portfolio in Review

As of Q1 2018, Candriam SCA held 808 positions worth $5.86B, up 1.4% from $5.78B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA's Q1 2018 filing shows 59 new, 345 increased, 246 reduced and 48 closed positions. Its largest new stake was Ecopetrol: 700,000 shares worth $13.5M. The largest sale was Baidu, an estimated $28.5M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2018 buy was Ecopetrol: 700,000 shares worth $13.5M.
  • Candriam SCA added most to Biogen in Q1 2018, an estimated $50M increase.
  • Candriam SCA's biggest Q1 2018 reduction was Baidu, cutting an estimated $28.5M.
  • Candriam SCA fully exited Sociedad Química y Minera de Chile in Q1 2018, selling an estimated $13.4M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.86B portfolio in Q1 2018.
  • Candriam SCA opened 59 new positions and closed 48 in Q1 2018.
  • Candriam SCA's portfolio value rose 1.4% quarter-over-quarter to $5.86B.

Based on Candriam SCA's 13F filing for Q1 2018, filed 9 May 2018.